Evidence map›Paper›PMID 42820305›Full record

ArticleThe Journal of clinical investigation2026

Loss of Smad4 drives vascular malformations via c-KIT-dependent high-fluid shear stress mimicry.

Johannes Gahn, Fan Wu, Qing Zhang, Yuxi Di, Tanmaya Behera, Yonggang Ren, Zohrah Hashemi, Kuheli Banerjee, Julio Cordero, Claudia Gherman and 6 more

Abstract read
In one paragraph

Article in The Journal of clinical investigation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Johannes GahnExperimental Pharmacology Mannheim (EPM) and.
Fan WuExperimental Pharmacology Mannheim (EPM) and.
Qing ZhangExperimental Pharmacology Mannheim (EPM) and.
Yuxi DiExperimental Pharmacology Mannheim (EPM) and.
Tanmaya BeheraExperimental Pharmacology Mannheim (EPM) and.
Yonggang RenDepartment of Cardiovascular Genomics and Epigenomics, European Center for Angioscience (ECAS), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Zohrah HashemiExperimental Pharmacology Mannheim (EPM) and.
Kuheli BanerjeeExperimental Pharmacology Mannheim (EPM) and.
Julio CorderoDepartment of Cardiovascular Genomics and Epigenomics, European Center for Angioscience (ECAS), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Claudia GhermanIon Chiricuta Oncological Institute, Cluj Napoca, Romania.
Kornelia AndorferDepartment of Otorhinolaryngology, Regensburg University Medical Center, Regensburg, Germany.
Caroline T SeebauerDepartment of Otorhinolaryngology, Head and Neck Surgery, Luzerner Kantonsspital, Lucerne, Switzerland.
Fatemeh Mirzapour-ShafiyiCenter for Synthetic Biology, Technical University Darmstadt, Darmstadt, Germany.
Gergana DobrevaDepartment of Cardiovascular Genomics and Epigenomics, European Center for Angioscience (ECAS), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Martin A SchwartzYale Cardiovascular Research Center, Departments of Internal Medicine (Cardiology), Cell Biology, and Biomedical Engineering, Yale School of Medicine, New Haven, Connecticut, USA.
Roxana OlaExperimental Pharmacology Mannheim (EPM) and.

Funding

Flow regulation of the Alk1/Eng pathway in vascular homeostasis and diseaseR01HL169510 · NHLBI · YALE UNIVERSITY · PI Anne Christine Eichmann, Martin A Schwartz · 2023 to 2026
$3.0M
NHLBI NIH HHS R01 HL169510
6 · The paper itself

Abstract

Vascular endothelial cells (ECs) encode a homeostatic fluid shear stress (FSS) set point that is essential for vascular stability. Deviations above or below this threshold trigger adaptive remodeling to restore physiological shear levels. Disruption of this control mechanism leads to enlarged arteriovenous malformations (AVMs) in hereditary hemorrhagic telangiectasia, a vascular disorder caused by heterozygous loss-of-function (LOF) mutation in ALK1, ENG, or SMAD4. Mechanistically, Smad4-deficient ECs are reset to a lower FSS set point value, resulting in AVMs that show characteristics of high-FSS remodeling with elevated KLF4 and high activation of the downstream Akt. Here, we investigated the KLF4/Akt upstream mechanisms by which SMAD4 sets the physiological FSS set point. We identified the receptor tyrosine kinase c-KIT as a component and regulator of the junctional mechanosensory receptor complex, which is highly upregulated in murine and human AVMs. SMAD4 restrains flow signaling by limiting c-KIT-dependent ERK5 activation and KLF4 induction. Thus, SMAD4 LOF leads to sustained c-KIT engagement in the sensory junctional apparatus, driving enhanced and prolonged activation of the ERK5/KLF4/Akt signaling axis. These results show that Smad4-LOF mutations induce malformations by disabling a key homeostatic mechanism and identify c-KIT as a potentially previously unrecognized therapeutic target.

Indexed as

Arteriovenous MalformationsLoss of Function MutationProto-Oncogene Proteins c-kitSmad4 ProteinAnimalsEndothelial CellsHumansKruppel-Like Factor 4MiceMice, KnockoutProto-Oncogene Proteins c-aktStress, MechanicalTelangiectasia, Hereditary HemorrhagicKIT protein, humanKLF4 protein, humanKlf4 protein, mouseKruppel-Like Factor 4Proto-Oncogene Proteins c-aktProto-Oncogene Proteins c-kitSmad4 ProteinSMAD4 protein, humanSmad4 protein, mouseCardiovascular diseaseCell biologyGeneticsMolecular biologySignal transductionVascular biology

Identifiers

PMID42820305
PMCPMC13626832

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.